Biosciences
Neurocrine Biosciences and Takeda’s Collaborative Drug Shows Promising Results in Phase II Clinical Trial for Depression
Neurocrine Biosciences, Takeda, drug candidate, Phase II clinical trial, depression, promising results.
Neurocrine Biosciences and Takeda’s Collaborative Depression Program Achieves Mid-Stage Success
Neurocrine Biosciences, Takeda, depression program, mid-stage success, clinical trials, mental health, pharmaceutical collaboration.
Sanofi Downsizes IGM Antibody Deal, Reduces Oncology Focus
Sanofi, IGM Biosciences, antibody deal, oncology, downsizing, partnership